Compare PAVM & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAVM | DOMH |
|---|---|---|
| Founded | 2014 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 69.2M |
| IPO Year | 2016 | N/A |
| Metric | PAVM | DOMH |
|---|---|---|
| Price | $7.29 | $4.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $510.00 | N/A |
| AVG Volume (30 Days) | 25.3K | ★ 314.8K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | ★ 15.36% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 9.19 |
| Revenue | $29,000.00 | ★ $99,588,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $450.56 | N/A |
| P/E Ratio | ★ N/A | $0.47 |
| Revenue Growth | N/A | ★ 691.07 |
| 52 Week Low | $6.00 | $1.00 |
| 52 Week High | $26.85 | $13.58 |
| Indicator | PAVM | DOMH |
|---|---|---|
| Relative Strength Index (RSI) | 91.78 | 47.30 |
| Support Level | $6.26 | $4.21 |
| Resistance Level | $9.26 | $5.10 |
| Average True Range (ATR) | 0.47 | 0.29 |
| MACD | 0.82 | 0.01 |
| Stochastic Oscillator | 78.39 | 27.78 |
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.